Title: Rheumatoid Arthritis - Pipeline Review, H1 2015
1Rheumatoid Arthritis - Pipeline Review, H1 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2 Report Overview
- Scope
- The report provides a snapshot of the global
therapeutic landscape of Rheumatoid Arthritis - The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players involved in the
therapeutics development for Rheumatoid Arthritis
and enlists all their major and minor projects - The report summarizes all the dormant and
discontinued pipeline projects - A review of the Rheumatoid Arthritis products
under development by companies and
universities/research institutes based on
information derived from company and
industry-specific sources - Pipeline products coverage based on various
stages of development ranging from
pre-registration till discovery and undisclosed
stages - A detailed assessment of monotherapy and
combination therapy pipeline projects - Coverage of the Rheumatoid Arthritis pipeline on
the basis of target, MoA, route of administration
and molecule type - Latest news and deals relating related to
pipeline products - Read More At http//www.researchbeam.com/rheumat
oid-arthritis-pipeline-review-h1-2015-market
3 Table of Content
Table of Contents 2Introduction 12Rheumatoid
Arthritis Overview 13Therapeutics Development
14Rheumatoid Arthritis - Therapeutics under
Development by Companies 16Rheumatoid Arthritis
- Therapeutics under Investigation by
Universities/Institutes 36Rheumatoid Arthritis -
Pipeline Products Glance 40Rheumatoid Arthritis
- Products under Development by Companies
44Rheumatoid Arthritis - Products under
Investigation by Universities/Institutes
72Rheumatoid Arthritis - Companies Involved in
Therapeutics Development 75Rheumatoid Arthritis
- Therapeutics Assessment 291Drug Profiles
324Rheumatoid Arthritis - Recent Pipeline
Updates 892Rheumatoid Arthritis - Dormant
Projects 1027Rheumatoid Arthritis - Discontinued
Products 1063Rheumatoid Arthritis - Product
Development Milestones 1074Appendix 1087
4 Report Overview
-
- Provides strategically significant competitor
information, analysis, and insights to formulate
effective RD development strategies - Identify emerging players with potentially strong
product portfolio and create effective
counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding
the focus areas of leading companies - Identify and understand important and diverse
types of therapeutics under development for
Rheumatoid Arthritis - Plan mergers and acquisitions effectively by
identifying key players of the most promising
pipeline - Devise corrective measures for pipeline projects
by understanding Rheumatoid Arthritis pipeline
depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and Scope - Modify the therapeutic portfolio by identifying
discontinued projects and understanding the
factors that drove them from pipeline - Enquire At http//www.researchbeam.com/rheumatoi
d-arthritis-pipeline-review-h1-2015-market/enquire
-about-report
5 FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/rheumatoid-arthritis-p
ipeline-review-h1-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com